FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.

about

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.

Item

http://www.wikidata.org/entity/Q47136604

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.

@en

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.

@nl

type

Item

label

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.

@en

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.

@nl

prefLabel

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.

@en

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.

@nl

P1476

FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate.

@en

P2093

Molly P Hogan

http://www.w3.org/2001/XMLSchema#string

P2860

Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.

Imaging of spinal metastatic disease

Methotrexate myelopathy after intrathecal chemotherapy: a case report

Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.

Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.

Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma.

A case of the cauda equina syndrome associated with the intrathecal chemotherapy in a patient with primary central nervous system lymphoma.

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.

Central nervous system prophylaxis with combined intravenous and intrathecal methotrexate in diffuse lymphoma of aggressive histologic type.

P304

995-997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/RLU.0000000000001440

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gary A Ulaner

Joseph R Osborne

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27805919

http://www.w3.org/2001/XMLSchema#string

P932

5583704

http://www.w3.org/2001/XMLSchema#string